IBDEI1PS ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29113,1,3,0)
 ;;=3^Maternal care for oth rhesus isoimmun, third tri, fetus 4
 ;;^UTILITY(U,$J,358.3,29113,1,4,0)
 ;;=4^O36.0934
 ;;^UTILITY(U,$J,358.3,29113,2)
 ;;=^5016886
 ;;^UTILITY(U,$J,358.3,29114,0)
 ;;=O36.0935^^115^1455^199
 ;;^UTILITY(U,$J,358.3,29114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29114,1,3,0)
 ;;=3^Maternal care for oth rhesus isoimmun, third tri, fetus 5
 ;;^UTILITY(U,$J,358.3,29114,1,4,0)
 ;;=4^O36.0935
 ;;^UTILITY(U,$J,358.3,29114,2)
 ;;=^5016887
 ;;^UTILITY(U,$J,358.3,29115,0)
 ;;=O36.1110^^115^1455^19
 ;;^UTILITY(U,$J,358.3,29115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29115,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, unsp
 ;;^UTILITY(U,$J,358.3,29115,1,4,0)
 ;;=4^O36.1110
 ;;^UTILITY(U,$J,358.3,29115,2)
 ;;=^5016893
 ;;^UTILITY(U,$J,358.3,29116,0)
 ;;=O36.1111^^115^1455^20
 ;;^UTILITY(U,$J,358.3,29116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29116,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 1
 ;;^UTILITY(U,$J,358.3,29116,1,4,0)
 ;;=4^O36.1111
 ;;^UTILITY(U,$J,358.3,29116,2)
 ;;=^5016894
 ;;^UTILITY(U,$J,358.3,29117,0)
 ;;=O36.1112^^115^1455^21
 ;;^UTILITY(U,$J,358.3,29117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29117,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 2
 ;;^UTILITY(U,$J,358.3,29117,1,4,0)
 ;;=4^O36.1112
 ;;^UTILITY(U,$J,358.3,29117,2)
 ;;=^5016895
 ;;^UTILITY(U,$J,358.3,29118,0)
 ;;=O36.1113^^115^1455^22
 ;;^UTILITY(U,$J,358.3,29118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29118,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 3
 ;;^UTILITY(U,$J,358.3,29118,1,4,0)
 ;;=4^O36.1113
 ;;^UTILITY(U,$J,358.3,29118,2)
 ;;=^5016896
 ;;^UTILITY(U,$J,358.3,29119,0)
 ;;=O36.1114^^115^1455^23
 ;;^UTILITY(U,$J,358.3,29119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29119,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 4
 ;;^UTILITY(U,$J,358.3,29119,1,4,0)
 ;;=4^O36.1114
 ;;^UTILITY(U,$J,358.3,29119,2)
 ;;=^5016897
 ;;^UTILITY(U,$J,358.3,29120,0)
 ;;=O36.1115^^115^1455^24
 ;;^UTILITY(U,$J,358.3,29120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29120,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, first tri, fetus 5
 ;;^UTILITY(U,$J,358.3,29120,1,4,0)
 ;;=4^O36.1115
 ;;^UTILITY(U,$J,358.3,29120,2)
 ;;=^5016898
 ;;^UTILITY(U,$J,358.3,29121,0)
 ;;=O36.1120^^115^1455^25
 ;;^UTILITY(U,$J,358.3,29121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29121,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, unsp
 ;;^UTILITY(U,$J,358.3,29121,1,4,0)
 ;;=4^O36.1120
 ;;^UTILITY(U,$J,358.3,29121,2)
 ;;=^5016900
 ;;^UTILITY(U,$J,358.3,29122,0)
 ;;=O36.1121^^115^1455^26
 ;;^UTILITY(U,$J,358.3,29122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29122,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 1
 ;;^UTILITY(U,$J,358.3,29122,1,4,0)
 ;;=4^O36.1121
 ;;^UTILITY(U,$J,358.3,29122,2)
 ;;=^5016901
 ;;^UTILITY(U,$J,358.3,29123,0)
 ;;=O36.1122^^115^1455^27
 ;;^UTILITY(U,$J,358.3,29123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29123,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 2
 ;;^UTILITY(U,$J,358.3,29123,1,4,0)
 ;;=4^O36.1122
 ;;^UTILITY(U,$J,358.3,29123,2)
 ;;=^5016902
 ;;^UTILITY(U,$J,358.3,29124,0)
 ;;=O36.1123^^115^1455^28
 ;;^UTILITY(U,$J,358.3,29124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29124,1,3,0)
 ;;=3^Maternal care for Anti-A sensitization, second tri, fetus 3
 ;;^UTILITY(U,$J,358.3,29124,1,4,0)
 ;;=4^O36.1123
 ;;^UTILITY(U,$J,358.3,29124,2)
 ;;=^5016903
